Imperial College London
Portrait Picture

DrAdamFrampton

Faculty of Medicine, Department of Surgery & Cancer

Honorary Clinical Lecturer
 
 
 
//

Contact

 

+44 (0)20 7594 2125a.frampton

 
 
//

Location

 

4005Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Patel:2021:10.1016/j.ejso.2020.11.146,
author = {Patel, BY and White, L and Gavriilidis, P and Satyadas, T and Frampton, AE and Pai, M},
doi = {10.1016/j.ejso.2020.11.146},
journal = {Eur J Surg Oncol},
pages = {970--978},
title = {A systematic review into patient reported outcomes following pancreaticoduodenectomy for malignancy.},
url = {http://dx.doi.org/10.1016/j.ejso.2020.11.146},
volume = {47},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BACKGROUND: Pancreaticoduodenectomy is associated with high rates of morbidity. This combined with the psychological burden of cancer, may impact on a patient's quality of life (QoL), which can be measured by using patient-reported outcomes (PRO). OBJECTIVE: To perform a systematic review to evaluate the measurement of PRO after pancreaticoduodenectomy for cancer. METHODS: 7 different databases were searched using 2 groups of search terms, one relating to pancreaticoduodenectomy, and one to PRO. Three authors screened the search results independently in a systematic manner based on predefined inclusion and exclusion criteria. RESULTS: 27 studies, with 2173 eligible patients were included in the final analysis. Most of the included studies used validated instruments. The European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire was most popular and used in 12 studies. The methodology of all included studies was also scrutinised. 12 studies were deemed to have high quality methodology according to pre-defined criteria. CONCLUSION: The instruments and methods used to measure PRO are variable. The quality of PRO within the available literature has improved over time, as has the number of studies measuring PRO. PRO should be measured with uniformity in future trials so that patients can be provided with more comprehensive information regarding post-operative recovery and QoL during the shared decision-making process preoperatively.
AU  - Patel,BY
AU  - White,L
AU  - Gavriilidis,P
AU  - Satyadas,T
AU  - Frampton,AE
AU  - Pai,M
DO  - 10.1016/j.ejso.2020.11.146
EP  - 978
PY  - 2021///
SP  - 970
TI  - A systematic review into patient reported outcomes following pancreaticoduodenectomy for malignancy.
T2  - Eur J Surg Oncol
UR  - http://dx.doi.org/10.1016/j.ejso.2020.11.146
UR  - https://www.ncbi.nlm.nih.gov/pubmed/33339639
VL  - 47
ER  -
Download